We are live on !
Find out more
First Manhattan Portfolio holdings
AUM
$39.2B
Turnover
13.59%
1-Year Est. Return
21.04%
This Fund
S&P 500
This Quarter Est. Return
+15.47%
1 Year Est. Return
+21.04%
3 Year Est. Return
+83.94%
5 Year Est. Return
+115.5%
10 Year Est. Return
+416.22%
AUM
$39.2B
AUM Growth
+$3.18B
(+8.8%)
Cap. Flow
-$457M
Cap. Flow % of AUM
Cap. Flow %
-1.17%
Top 10 Holdings %
Top 10 Hldgs %
52.64%
Holding
802
New
49
Increased
157
Reduced
365
Closed
60
Avg Time Held
7.2
years
Top 10 Avg Time Held
7.7
years
Top 20 Avg Time Held
5.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HONA
Honeywell Aerospace
HONA
|
+$414M |
| 2 |
Uber
UBER
|
+$206M |
| 3 |
Workday
WDAY
|
+$81M |
| 4 |
Wolfspeed
WOLF
|
+$71.6M |
| 5 |
EagleRock Land
EROK
|
+$70.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$175M |
| 2 |
Salesforce
CRM
|
+$159M |
| 3 |
Kinsale Capital Group
KNSL
|
+$138M |
| 4 |
Applied Materials
AMAT
|
+$122M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 39.52% |
| 2 | Technology | 24.2% |
| 3 | Consumer Discretionary | 7.77% |
| 4 | Communication Services | 6.34% |
| 5 | Industrials | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
726
Eos Energy Enterprises
EOSE
$623M
| $135K | ﹤0.01% |
23,000
| – | – |
2025 Q4
2 quarters
|
|
727
Nuveen California Municipal Value Fund
NCA
$284M
| $127K | ﹤0.01% |
13,621
| – | – |
2025 Q1
5 quarters
|
|
728
Immuneering
IMRX
$246M
| $121K | ﹤0.01% |
24,245
| – | – |
2024 Q4
6 quarters
|
|
729
Iovance Biotherapeutics
IOVA
$6.41B
| $116K | ﹤0.01% |
27,998
-1,000
| -3% | -$3.8K |
2025 Q3
3 quarters
|
|
730
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$815M
| $108K | ﹤0.01% |
10,010
| – | – |
2025 Q1
5 quarters
|
|
731
Valens Semiconductor
VLN
$159M
| $98.2K | ﹤0.01% |
43,458
| – | – |
2024 Q1
9 quarters
|
|
732
United-Guardian
UG
$31.2M
| $93.3K | ﹤0.01% |
13,062
-3,000
| -19% | -$20.8K |
2013 Q2
52 quarters
|
|
733
ImmunityBio
IBRX
$8.81B
| $87.6K | ﹤0.01% |
+10,000
| New | +$75.7K |
2026 Q2
0 quarters
|
|
734
Opko Health
OPK
$1.22B
| $78.2K | ﹤0.01% |
52,150
| – | – |
2013 Q2
52 quarters
|
|
735
Ovid Therapeutics
OVID
$463M
| $69.9K | ﹤0.01% |
26,000
| – | – |
2019 Q3
27 quarters
|
|
736
Arbutus Biopharma
ABUS
$834M
| $67.2K | ﹤0.01% |
14,000
| – | – |
2023 Q1
13 quarters
|
|
737
Kaltura
KLTR
$220M
| $65K | ﹤0.01% |
50,000
| – | – |
2022 Q1
17 quarters
|
|
738
Grove Collaborative
GROV
$43.1M
| $14.6K | ﹤0.01% |
11,662
| – | – |
2022 Q4
14 quarters
|
|
739
Alcoa
AA
$10.2B
| – | – |
-3,250
| Closed | -$216K | – |
|
740
Airbnb
ABNB
$104B
| – | – |
-2,395
| Closed | -$302K | – |
|
741
DELISTED
Air Lease Corp
AL
| – | – |
-8,000
| Closed | -$521K | – |
|
742
Aldeyra Therapeutics
ALDX
$38.9M
| – | – |
-34,745
| Closed | -$58.7K | – |
|
743
A.O. Smith
AOS
$8.49B
| – | – |
-3,246
| Closed | -$214K | – |
|
744
Atlantic Union Bankshares
AUB
$5.73B
| – | – |
-10,320
| Closed | -$369K | – |
|
745
Booz Allen Hamilton
BAH
$9.45B
| – | – |
-353,892
| Closed | -$27.6M | – |
|
746
Southern California Bancorp
BCAL
$710M
| – | – |
-11,682
| Closed | -$208K | – |
|
747
Builders FirstSource
BLDR
$6.19B
| – | – |
-4,071
| Closed | -$335K | – |
|
748
Bruker
BRKR
$8.73B
| – | – |
-14,631
| Closed | -$529K | – |
|
749
Camden National
CAC
$978M
| – | – |
-6,750
| Closed | -$320K | – |
|
750
CalciMedica
CALC
$7.85M
| – | – |
-2,645
| Closed | -$7.14K | – |
|
Similar funds
First Manhattan's Q2 2026 Portfolio in Review
As of Q2 2026, First Manhattan held 802 positions worth $39.2B, up 8.8% from $36.1B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
First Manhattan's Q2 2026 filing shows 49 new, 157 increased, 365 reduced and 60 closed positions. Its largest new stake was Honeywell Aerospace: 1,875,740 shares worth $415M. The largest sale was Boston Scientific, an estimated $175M.
By sector, the portfolio is most concentrated in Financials at 40% of assets, down from 42% a quarter earlier, followed by Technology and Consumer Discretionary.
- First Manhattan's largest Q2 2026 buy was Honeywell Aerospace: 1,875,740 shares worth $415M.
- First Manhattan added most to Uber in Q2 2026, an estimated $206M increase.
- First Manhattan's biggest Q2 2026 reduction was Boston Scientific, cutting an estimated $175M.
- First Manhattan fully exited Booz Allen Hamilton in Q2 2026, selling an estimated $27.6M.
- First Manhattan's ten largest holdings make up 53% of its $39.2B portfolio in Q2 2026.
- First Manhattan opened 49 new positions and closed 60 in Q2 2026.
- First Manhattan's portfolio value rose 8.8% quarter-over-quarter to $39.2B.
Based on First Manhattan's 13F filing for Q2 2026, filed 14 Aug 2026.